Tencent invests $30m into HK-based early cancer detection firm

Insighta, valued at $200m, uses a system designed to detect DNA methylation aberrations in cell-free DNA in bodily fluids such as blood; Prenetics has reduced its stake in the firm.

Tencent has made a $30 million investment into Insighta, a Hong Kong-based early cancer detection company, from health sciences firm Prenetics Global.

¬ Haymarket Media Limited. All rights reserved.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media